- ECM
extracellular matrix
- ERK
extracellular signal-regulated kinase
- LPS
lipopolysaccharide
- NAC
N-acetyl cysteine
- ROS
reactive oxygen species
- TCR
T-cell receptor
- ΔTrspT
conditional knockout of Trsp in T-cells
- ΔTrspM
conditional knockout of Trsp in macrophage
Roles of selenium in immune function
Selenium (Se) is an important micronutrient in the diet of human individuals and other mammals. It is known to serve a wide variety of functions in health and development including roles in cancer and heart disease prevention, viral inhibition, male reproduction and the immune function, delaying the ageing process and the onset of AIDS in HIV positive patients(Reference Hatfield, Berry and Gladyshev1). Interestingly, of all these health benefits attributed to Se, a role of this element in boosting the immune function was amongst the first indications that Se, which incidentally was long thought to be a toxin(Reference Oldfield, Hatfield, Berry and Gladyshev2), served as an advantageous agent in health. That is, only 2 years after Se was shown to prevent liver necrosis in rats, which provided the first demonstration that this element was essential in the diet of mammals(Reference Schwarz and Foltz3), McConnell injected 75Se into dogs and found that the isotope was incorporated in leucocytes(Reference McConnell4). Since this early finding, numerous studies have suggested roles of Se in both the adaptive and innate immune systems(Reference Bainbridge5–Reference Turner and Finch15). The mechanism of how Se acts at the molecular level in boosting the immune system is only beginning to be understood, primarily through the action of selenoproteins(Reference Hoffmann16, Reference Hoffmann and Berry17). The possible action of small molecular weight selenocompounds in enhancing immune activity has not been examined. The focus of this paper is on the role of selenoproteins in the immune system. Several excellent reviews on Se in the immune system have recently been published. They provide an in-depth analysis of wide range benefits that Se offers in the immune function(Reference Hoffmann16–Reference Arthur, McKenzie and Beckett18).
Selenium metabolism in mammals
The possible means of how selenium is metabolized in mammalian systems is shown in Fig. 1. Se can potentially make its way into protein by multiple pathways, but only one of these pathways is used to specifically incorporate this element into selenoproteins: through the Se-containing amino acid, selenocysteine (Sec), the 21st amino acid in the genetic code(Reference Hatfield and Gladyshev19). Sec is programmed to be inserted into protein by the stop codon, UGA, and thus, this codeword serves as a dual function in mammals. Its biosynthesis occurs by a novel pathway in eukaryotes in that the synthesis is carried out on Sec tRNA, designated Sec tRNA[Ser]Sec and proceeds as follows: (1) serine is attached to tRNA[Ser]Sec in the presence of seryl-tRNA synthetase and ATP to form Ser-tRNA[Ser]Sec; (2) the seryl moiety is phosphorylated in the presence of O-phosphoseryl-tRNA[Ser]Sec kinase and ATP to form O-phosphoseryl-tRNA[Ser]Sec and (3) O-phosphoseryl-tRNA[Ser]Sec in turn serves as a substrate for Sec synthase. In this reaction, monoselenophosphate, which is the active donor of Se, donates Se to the acceptor intermediate generated by Sec synthase to yield selenocysteyl-tRNA[Ser]Sec. Monoselenophosphate is synthesized by selenophosphate synthetase 2 from selenide (or other Se compounds) and ATP. The details of Sec biosynthesis have been reviewed elsewhere(Reference Xu, Carlson and Zhang20). The other pathways wherein Se can be non-specifically incorporated into protein, namely by selenomethionine replacing methionine and Sec replacing cysteine, may result in deleterious effects to the cell, especially if such insertion occurs to any appreciable extent.
Roles of selenoproteins in the immune function
In our studies examining the role of selenoproteins in T-cell development, we have taken advantage of the fact that selenoprotein synthesis is dependent on Sec tRNA which is responsible for inserting this Se-containing amino acid into protein. By targeting the removal of the floxed Sec tRNA gene, designated Trsp, in T-cells or macrophage of mice by Cre-recombinase under control of the Lck promoter or the lysozyme M promoter, we generated selenoprotein-deficient T-cells(Reference Shrimali, Irons and Carlson21) or selenoprotein-deficient macrophage(Reference Carlson, Yoo and Sano22), respectively. The expression of selenoproteins in these two cell types and the consequences of the loss of selenoprotein expression in these cell types on immunity are discussed later. Another study involving the targeted removal of Trsp in macrophages and simultaneously Nrf2, a transcription factor that regulates antioxidant enzyme expression, demonstrated that knockout mice manifested a reduction in viability and an increase in oxidative stress and susceptibility to hydrogen peroxide compared to mice in which either of the two genes was knocked out(Reference Suzuki, Kelly and Motohashi23). Mice in which only Trsp was targeted for removal of macrophage had an increase in the gene expression involving oxidative stress and detoxification enzymes. These results, along with several lines of clinical evidence mentioned above prompted us to examine whether selenoproteins link redox regulation to immunity and inflammation in mammals.
Selenoproteins in T-cells
mRNA expression and T-cell development
There are 24 selenoprotein genes in mice(Reference Kryukov, Castellano and Novoselov24) and individual selenoproteins and selenoprotein mRNA manifest tissue specificity in their patterns of expression and in the manner in which their expression is regulated(Reference Hoffmann, Hoge and Li25). We examined the expression of the mRNA levels transcribed from each of the 24 selenoprotein genes by isolating total RNA from the three lymphoid organs, lymph nodes, spleen and thymus of normal mice and analysing the expression by real-time PCR. As shown in Fig. 2(A), GPx1 mRNA was highly expressed in all three organs. Several other selenoprotein mRNA, namely Sep15, GPx4, SelP, SelK, SelT and SelH, were moderately-to-highly expressed in each organ. Several additional selenoprotein mRNA were also made, while others were only slightly, or not at all, detectable. It is not clear why there is some variation in the levels of selenoprotein mRNA expression between the three tissues.
We also examined selenoprotein expression in T-cells by labelling control and selenoprotein deficient (ΔTrspT) mice with 75Se, isolating the T-cells from the thymus and examining the labelled selenoproteins by gel electrophoresis (Fig. 2(B)). Several selenoproteins were labelled in control mice, some of which have been identified in earlier studies(Reference Gladyshev, Stadtman and Hatfield26). Virtually no selenoproteins were labelled in the ΔTrspT T-cells and the faint labelling is most likely due to contamination from other cell types(Reference Carlson, Novoselov and Kumaraswamy27).
The thymus, spleen and lymph nodes of the affected mice manifested moderate-to-severe atrophy wherein their mass and cellularity were decreased to varying degrees ranging between 50% and 80% of those of control mice. The T-cell population in lymphoid organs, which was analysed by flow cytometry, was altered significantly. For example, the CD3+ population in splenocytes of ΔTrspT mice was about 50% of that of control splenocytes, while the CD8+ T-cell sub-population was more substantially reduced (>50%). Although the consequences of the partial loss of functional T-cells and in particular CD8+ T-cells, was not clearly defined in our study, other studies have shown that Se deficiency in the diet, which is known to cause a loss or reduction in selenoprotein function, impairs antiviral immunity and exacerbates viral pathogenesis(Reference Beck28, Reference Hurwitz, Klaus and Llabre29).
T-cell activation
We next tested the ability of selenoprotein-deficient T-cells to be activated by T-cell receptor (TCR) signalling. Purified control T-cells and ΔTrspT T-cells were cultured in the presence or absence of anti-CD28 and anti-CD3 antibodies wherein the presence of these antibodies mimicked TCR activation and stimulated T-cells to proliferate(Reference Shrimali, Irons and Carlson21). The amount of 3H-thymidine incorporated into both cell lines was measured after 60 h as an indication of the level of proliferation. Control cells incubated with both antibodies manifested a far more pronounced level of proliferation compared to unstimulated cells, whereas the level of proliferation of ΔTrspT T-cells was dramatically reduced under the same conditions (Fig. 3(A)). The data suggested that selenoprotein expression appeared to be essential for the ability of T-cells to proliferate in response to TCR stimulation.
Since TCR activation is known to produce IL-2 in T-cells and generate T-cell IL-2 receptor expression, we initially examined IL-2 production in control and ΔTrspT T-cells (Fig. 3(B))(Reference Shrimali, Irons and Carlson21). Both cell lines produced similar amounts of IL-2 in response to TCR activation. However, ΔTrspT T-cells manifested a much reduced IL-2 receptor induction compared to control cells (Fig. 3(C)).
Since TCR is coupled to multiple signalling pathways and it is known that mitogen-activated protein kinase extracellular signal-regulated kinase (ERK) links TCR activation to T-cell proliferation(Reference Pages, Guerin and Grall30), we examined ERK activation in control and selenoprotein-deficient T-cells in response to stimulation with CD3/CD28 antibodies(Reference Shrimali, Irons and Carlson21). As shown in Fig. 3(D), T-cells from ΔTrspT mice manifested a very slight appearance of the phosphorylated or active forms of ERK following the treatment with anti-CD3 and anti-CD28 antibodies, while T-cells from control mice manifested a rapid appearance of the active forms of ERK.
The above data demonstrated that the loss of selenoprotein expression in T-cells resulted in defects in the development of functionally mature T-cells and their TCR-dependent activation. It is highly likely that such anomalies result in an impairment in T-cell-mediated immune responses. To further examine this possibility, control and ΔTrspT mice were immunized with NP-OVA ((4-hydroxy-3-nitrophenyl)acetyl-ovalbumin), an antigen that stimulates T-cell antibody production. Serum was taken from the immunized mice at different time periods after immunization and the levels of antigen-specific Ig were assessed by ELISA. Of the several Ig classes examined, IgM, IgG1, IgG2a, IgG2b and IgG3, the serum levels of antigen-specific antibodies were poorly raised in ΔTrspT mice (Fig. 3(E)). Thus, these data suggest that selenoproteins play an important role in T-cell immunity.
Reactive oxygen species in ΔTrspT T-cells
Since several selenoproteins are known to act as antioxidants and therefore have roles in protecting cells against oxidative stress, we examined whether selenoprotein-deficient T-cells produce higher levels of reactive oxygen species (ROS) than the corresponding control cells and how this may relate to T-cell defects in ΔTrspT mice. To elucidate the basal and TCR-stimulated ROS generation in ΔTrspT and control cells, we labelled the cells with cell-permeable, oxidation-sensitive DCFDA (2′-7′-dichlorofluorescin diacetate) dye. Interestingly, as shown in Fig. 4(A), the oxidation of DCFDA due to the generation of ROS was present to a greater extent in T-cells of ΔTrspT mice than in control mice even without TCR stimulation. TCR stimulation enhanced the ROS production in control cells, but had little effect on the ROS levels in ΔTrspT T-cells. The data suggest that selenoproteins have a major role in suppressing ROS production in T-cells and that the loss of this protein class results in T-cells being defective in TCR-induced and ROS-sensitive responses.
Finally, ΔTrspT T-cells were incubated in the presence of N-acetyl cysteine (NAC), which is known to block endogenously produced ROS, to assess whether this reagent can restore the ability of these cells to proliferate in response to TCR stimulation (Fig. 4B). The ability of the selenoprotein-deficient T-cells to proliferate in response to TCR stimulation was restored by NAC treatment. NAC alone did not induce T-cell proliferation. These observations suggest that selenoproteins are essential for reducing ROS generation in T-cells and that ROS production prevents T-cell activation.
Selenoproteins in macrophages
Selenoprotein mRNA, selenoprotein expression and reactive oxygen species levels
To determine the relative expression levels of selenoproteins mRNA in mouse macrophages, the total RNA was isolated from bone marrow-derived normal macrophages and the expression of mRNA levels transcribed from all 24 mouse selenoprotein genes were analysed by real-time PCR. As shown in Fig. 5(A), relatively high levels of selenoprotein mRNA corresponding to GPx1, GPx4, TR1, Sep15, and selenoproteins P, R, K and T and selenophosphate synthetase 2 were expressed. Interestingly, the most highly expressed selenoprotein mRNA in macrophage, like that in T-cells (see earlier), was GPx1 and a major role of this selenoenzyme is as an antioxidant. Similarly, Sep15, GPx4 and selenoproteins P, K and T were also highly expressed in macrophages.
We deleted Trsp in macrophage (ΔTrspM) and examined the effects of Trsp loss on selenoprotein expression and function. Initially, we demonstrated that Trsp was no longer expressed in this cell type (Fig. 5(B)). Selenoprotein expression was also examined in macrophages by incubating the bone marrow-derived macrophages from control and ΔTrspM mice in the presence of 75Se and electrophoresing a protein extract on a polyacrylamide gel (Fig. 5(C), left panel). Several selenoproteins whose mRNA were also detected by real-time PCR were visualized on the gel, while the expression of selenoproteins in ΔTrspM cells were almost completely abolished (Fig. 5(C), right panel). The low levels of Sec tRNA and selenoproteins observed in ΔTrspM macrophages in Fig. 5(B and C) are likely due to the contamination of the bone marrow-derived macrophage preparations with non-macrophage cells as has been observed in studies involving other cell types(Reference Carlson, Novoselov and Kumaraswamy27).
The functions of only about half of selenoproteins have been characterized and most are oxidoreductases and/or antioxidants(Reference Hatfield, Carlson and Xu31). Since selenoprotein-less T-cells accumulate higher ROS levels than the corresponding control cells (see Fig. 4(A)), ROS levels in ΔTrspM macrophages were also assessed by staining (Fig. 5(D and E)). Resting selenoprotein-deficient macrophages manifested higher steady state ROS levels than control macrophages.
In vitro and in vivo inflammatory responses
Due to the highly significant role that macrophages have in initiating inflammation, it was important to assess the ability of the corresponding selenoprotein-deficient T-cells in the inflammation process. Macrophages generate cytokines in response to tissue injury and microbial infection. The fact that several inflammatory stimuli such as lipopolysaccharide (LPS) cause transient ROS accumulation as part of cellular signalling events(Reference Hsu and Wen32, Reference Park, Jung and Park33), and several selenoproteins, e.g. GPx isoforms, which are known to regulate inflammatory responses(Reference Brigelius-Flohe, Friedrichs and Maurer34, Reference Esworthy, Aranda and Martin35), prompted us to examine the effect of selenoprotein deficiency and the resulting redox imbalance on macrophage inflammatory response. We initially treated control and ΔTrspM macrophages with LPS and examined the degradation and replenishment of IκBα. It should be noted that the transcription factor NF-κB, and mitogen-activated protein kinase (ERK, c-Jun N-terminal kinase and p38) signalling pathways are essential for cellular responses to inflammatory stimuli and that both the degradation and replenishment of IκBα are indicative of NF-κB activation. However, in LPS-treated control and ΔTrspM macrophages, the degradation and replenishment of IκBα occurred independently of the selenoprotein status and the induction of the active forms of the protein kinases (i.e., phosphorylated ERK, JNK and p38) was similar and therefore considered normal(Reference Carlson, Yoo and Sano22). Furthermore, comparison of LPS-induced inflammatory gene expression in the two bone marrow-derived macrophage groups and analyses of gene expression by real-time PCR revealed that the magnitude and kinetics of expression of the genes encoding the chemokines KC (Cxcl1), macrophage inflammatory protein-2 (Cxcl2) and the cytokines TNF-α and IL-1β were similar(Reference Carlson, Yoo and Sano22).
We next turned our attention to examining the effects of selenoprotein deficiency in macrophages on the pathology of mice by exposing control and ΔTrspM mice to various models of inflammatory response. The models used included zymosan-induced peritonitis, LPS endotoxemia and chemical irritant (12-O-tetradecanoylphorbol-13-acetate) dermatitis. In these models, control and ΔTrspM mice had comparable rates of neutrophil infiltration, rates of mortality and levels of cytokine production and local edema formation. Since in vitro and in vivo inflammatory responses in both control and ΔTrspM macrophages were similar, we have not shown the data, but refer the reader to the original work(Reference Carlson, Yoo and Sano22). Interestingly, the loss of selenoprotein expression and the deregulated ROS generation in ΔTrspM macrophages did not appear to cause any detectable detrimental effects concerning inflammatory responses.
Macrophage microarray analysis
Since there were unexpectedly little or no distinguishable inflammatory phenotypes in ΔTrspM mice, it seemed reasonable that selenoproteins may have other functions in macrophages in addition to roles in inflammatory gene expression. To explore this possibility, an analysis of the global gene expression profiles was carried out in control and ΔTrspM macrophages. We used whole-genome DNA microarrays from mice to assess the expression levels of mRNA in the two macrophage groups. Those genes that manifested a significantly higher or lower expression in ΔTrspM macrophages compared to control macrophages are shown in Fig. 6(A) and are designated by those dots (designating mRNA) that fell outside the lines above and below normal expression levels indicating significant changes.
The expression levels of those mRNA that showed significant changes in selenoprotein-deficient macrophages were verified by real-time PCR analysis (Fig. 6(B)). Interestingly, many genes that deviated significantly in their expression levels from normal in ΔTrspM macrophages were functionally related to the formation, remodelling cellular interaction with the extracellular matrix (ECM). Each of the ECM-related genes that we found to be significantly altered in ΔTrspM macrophages were up-regulated compared to the corresponding control cells (Fig. 6(C)). These included genes that encode ECM components (collagen chains, extracellular proteoglycans and secreted glycoproteins; Col1a1, Col5a2, Bgn and Ctgf), inhibitors of ECM proteolysis (metalloendopeptidase and serine-type endopeptidase inhibitors; Timp3 and Serpinh1) and ECM-induced cytoskeletal remodelling (actin-binding proteins; Tagln, Enah and Cald1).
Selenoprotein deficiency and macrophage invasiveness
The microarray analysis of ΔTrspM macrophages suggested that macrophage–ECM interactions were altered by the lack of selenoprotein expression in such a manner that matrix remodelling was decreased and the surrounding ECM was reinforced. Such effects might be expected to impair the migration of macrophages through the ECM and basement membrane. To test this possibility, we compared the invasiveness of control and ΔTrspM macrophages in a protein gel matrix. The migration of selenoprotein-deficient macrophages was dramatically reduced in the gel-laden transwell chambers (Fig. 7(A)). We repeated this assay, but without the gel in the transwell chamber to assess whether the gel invasion phenotype arose from a cell-intrinsic motility defect. Surprisingly, the migration of ΔTrspM macrophages was slightly higher than control macrophages (Fig. 7(B)) suggesting that the changes observed in ECM-related gene expression in macrophages appeared to decrease the ability of the cell to migrate only in surroundings consisting of ECM components.
Conclusion
Our data show that selenoproteins have an essential role in T-cell proliferation in response to TCR stimulation. Although there is substantial evidence that many selenoproteins function as antioxidants(Reference Hatfield, Carlson and Xu31), the fact that NAC can compensate for the loss of selenoprotein expression in T-cells and reverse their defect of TCR-induced proliferation provides further evidence that members of this Se-containing protein class serve to maintain redox homeostasis. Not unexpectedly, we observed elevated ROS generation in T-cells and macrophages. The fact that the ROS dysregulation in ΔTrspM macrophages did not result in altered inflammatory responses suggested that their increased levels and oxidative damage in selenoprotein-deficient T-cells were below the threshold to elicit effecting inflammatory responses. Selenoproteins were shown to also have a role in macrophage invasiveness.
Since GPx4 is one of the more highly expressed selenoproteins in both T-cells and macrophages, we are currently examining the effect of targeting the removal of this essential selenoenzyme(Reference Conrad, Schneider and Seiler36) in these two cell types. In addition, we are using mouse models to investigate the effects of deficient, adequate and supplemental levels of Se intake on the immune response mediated by T-cells against infectious disease resistance involving influenza virus (M Beck, B Carlson, R Shrimali, JM Park and D Hatfield, unpublished results) that do not express selenoproteins or express only essential, housekeeping selenoproteins, but not non-essential, stress-related selenoproteins(Reference Carlson, Moustafa and Sengupta37). This study will also allow us to characterize the critical Se metabolites (i.e. selenoproteins or low-molecular weight selenocompounds) involved in the immune function and examine their roles in resistance to infectious diseases. Recent epidemiological and molecular evidence suggest a strong link between metabolic regulatory mechanisms and immune homeostasis(Reference Hotamisligil38, Reference Hotamisligil and Erbay39). Our study has just begun to reveal how Se and selenoproteins function at the crossroads of metabolism and immunity. Future studies will seek to offer deeper insights into the effects of dietary Se on the onset and progression of immune disorders and help devise better-informed public health policies.
Acknowledgements
This research was supported by the Intramural Research Program of the National Institutes of Health, National Cancer Institute and Center for Cancer Research, and in addition, a specific grant from the Office of Dietary Supplements, NCI, NIH and the Cutaneous Biology Research Center through the Massachusetts General Hospital/Shiseido Co. Ltd. agreement to J. M. P. and NIH grants awarded to V. N. G. The authors declare that there are no conflicts of interest. B. A. C., M.-H. Y., R. K. S. and R. I. carried out the research and participated in the planning of experiments and the writing of the manuscript and V. N. G., D. L. H. and J. M. P. planned the experiments and wrote the manuscript. We thank the Journal of Biological Chemistry for the use of Figs. 1–4 and BMC Immunology for the use of Figs. 5–7 that were originally published therein.